Defining Pathologic Upstaging in cT1b Esophageal Cancer: Should We Consider Neoadjuvant Therapy?

Mann, David R; Engelhardt, Kathryn E; Gibney, Barry C; Batten, Macelyn E; Klipsch, Eric C; Mukherjee, Rupak; Bostock, Ian C

Mann, David R; Engelhardt, Kathryn E; Gibney, Barry C; Batten, Macelyn E; Klipsch, Eric C; Mukherjee, Rupak; Bostock, Ian C.

Afiliação

Mann DR; Department of Cardiothoracic Surgery, Medical University of South Carolina, Charleston, South Carolina.
Engelhardt KE; Department of Cardiothoracic Surgery, Medical University of South Carolina, Charleston, South Carolina.
Gibney BC; Department of Cardiothoracic Surgery, Medical University of South Carolina, Charleston, South Carolina.
Batten ME; Department of Cardiothoracic Surgery, Medical University of South Carolina, Charleston, South Carolina.
Klipsch EC; Department of Cardiothoracic Surgery, Medical University of South Carolina, Charleston, South Carolina.
Mukherjee R; Department of Cardiothoracic Surgery, Medical University of South Carolina, Charleston, South Carolina.
Bostock IC; Department of Cardiothoracic Surgery, Medical University of South Carolina, Charleston, South Carolina. Electronic address: bostockr@musc.edu.

J Surg Res ; 295: 61-69, 2024 Mar.

Article em En | MEDLINE | ID: mdl-37992454

Assuntos

Adenocarcinoma; Carcinoma de Células Escamosas; Neoplasias Esofágicas; Humanos; Terapia Neoadjuvante; Estadiamento de Neoplasias; Neoplasias Esofágicas/cirurgia; Adenocarcinoma/cirurgia; Esofagectomia; Estudos Retrospectivos; Resultado do Tratamento

Palavras-chave

Adult thoracic; Chemoradiation therapy; Esophageal cancer; Esophagectomy; Neoadjuvant; Treatment outcomes

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Carcinoma de Células Escamosas / Adenocarcinoma Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google